Lamotrigine
Product Images NDC 60760-543

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 60760-543). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

543 (Lamotrigine 543 30)

This is a description of a medication called Lamotrigine. It is available in the form of tablets and comes in a strength of 25mg. The medication is manufactured by Taro Pharmaceutical Industries Ltd based in Haifa Bay, Israel. The tablets are packaged by Sap, and have different quantities with RX and NDC numbers. The LOT and EXP numbers vary across different packs. The medication should be used as directed and stored in a controlled room temperature of 15-30C.*

FDA Label Image

Chemical Structure (Lamotrigine 01)

FDA Label Image

Figure 1 (Lamotrigine 02)

LAMOTRIGINE is a medication commonly used to treat seizures in epilepsy and bipolar disorder. However, the text provided is too short to give more details.*

FDA Label Image

Figure 2 (Lamotrigine 03)

This appears to be a graph or chart displaying the failure probability for a drug called lamotrigine compared to a placebo. The probabilities are measured on a scale of 0-100%. Without further context or a clear visual of the graph, it is difficult to interpret the data.*

FDA Label Image

Image (Lamotrigine 04)

FDA Label Image

Image (Lamotrigine 05)

FDA Label Image

Image (Lamotrigine 06)

FDA Label Image

Image (Lamotrigine 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.